Nigeria Takes Bold Steps Toward Local Vaccine Production 

Nigeria is intensifying its efforts to produce homegrown vaccines; a move aimed at reducing the country’s dependence on foreign supplies. According to the National Agency for Food and Drug Administration and Control (NAFDAC), the COVID-19 pandemic exposed major gaps in Nigeria’s healthcare system, especially in vaccine access. 

During the pandemic, wealthier nations secured most of the early global vaccine supplies, leaving countries like Nigeria struggling to protect their citizens. Now, NAFDAC is determined to ensure the country never faces such a shortage again. 

“Nigeria must not wait for another pandemic to build vaccine self-sufficiency,” — Prof. Mojisola Adeyeye, NAFDAC Director-General 

Strengthening Nigeria’s Vaccine Production System 

NAFDAC has restructured its operations and strengthened its regulatory framework for vaccines, biologics, and medical devices. The agency achieved World Health Organisation (WHO) Maturity Level 3 status for imported vaccines and medicines — proof that Nigeria’s regulatory system meets global standards. 

The next goal is to achieve ML3 for locally manufactured vaccines, which will qualify Nigeria for WHO prequalification — a critical step for global recognition and export potential. 

To make this possible, NAFDAC has: 

• Established a Directorate for Vaccines, Biologics, and Medical Devices. 

• Built an in-house vaccine testing laboratory — the only one of its kind in sub-Saharan Africa. 

• Strengthened clinical trial oversight, post-market surveillance, and pharmacovigilance to ensure vaccine safety and quality. 

These advancements provide a strong foundation for local manufacturers to begin “fill and finish” operations, an important early stage in vaccine production. 

How Nigerians Can Benefit 

This development is not just for policymakers — it directly benefits every Nigerian. 

• Better access to vaccines: Local production means faster and cheaper vaccine availability during outbreaks. 

• Job creation: Vaccine manufacturing will open new employment opportunities for scientists, engineers, and health workers. 

• Health security: Reducing dependence on foreign donors ensures Nigeria can respond swiftly to future pandemics. 

• Economic growth: The initiative aligns with the Federal Government’s Renewed Hope Agenda, promoting industrial growth and self-reliance. 

Nigeria’s renewed focus on local vaccine manufacturing represents a major leap toward healthcare independence and national preparedness. With NAFDAC’s strengthened capacity and the government’s commitment, the nation is positioning itself as a regional hub for vaccine production — one that protects lives, empowers industries, and secures the future of public health.